Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription 14.07.2025 1 BMC Neurol 1 Curr Opin Immunol 1 Diabetes 2 Intern Med 1 J Nephrol 1 J Neuroimmunol 4 J Neurol 1 J Pediatr Endocrinol Metab 3 Mult Scler 1 Neurol Clin Pract 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. QI F, Sun Q, Wang H, Zhang Y, et al
   Efgartigimod therapy for immune checkpoint inhibitor-associated myasthenia gravis with myositis: a case report.
   BMC Neurol. 2025;25:276.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

2. DEI ZOTTI F, Hudson KE
   Development and consequences of red blood cell autoantibodies: warm autoimmune hemolytic anemia.
   Curr Opin Immunol. 2025;95:102604.
   PubMed         Abstract available
   
   

   
   Diabetes

3. WASSERFALL CH, Forsmark CE, Li S, Li L, et al
   Type 1 Diabetes Autoantibodies in Acute, Recurrent Acute, and Chronic Pancreatitis.
   Diabetes. 2025 Jul 9:db240931. doi: 10.2337/db24-0931.
   PubMed         Abstract available
   
   

   
   Intern Med

4. MATSUDA Y, Kainaga M, Maeda M, Kitao H, et al
   An Anti-NH2 Terminal of alpha-enolase Antibody-positive Hashimoto's Encephalopathy with Bilateral Basal Ganglia Lesions: A Case Report and Literature Review.
   Intern Med. 2025 Jul 10. doi: 10.2169/internalmedicine.5692.
   PubMed         Abstract available
   
   
5. NAKAO Y, Mori Y, Kunieda J, Taguchi T, et al
   Successful Remission of Nephrotic Syndrome Caused by IgA Nephropathy with Membranoproliferative Glomerulonephritis-pattern Lesion Treated by Cyclosporine and Oral Corticosteroids.
   Intern Med. 2025 Jul 10. doi: 10.2169/internalmedicine.5526.
   PubMed         Abstract available
   
   

   
   J Nephrol

6. HIRANO K, Ikenoue T, Seki T, Komukai S, et al
   Development and validation of personalized risk prediction models for patients with IgA nephropathy: a nationwide multicenter cohort study.
   J Nephrol. 2025 Jul 11. doi: 10.1007/s40620-025-02338.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

7. WELSH NC, DiSano KD, Pike SC, Linzey M, et al
   Network analysis of intrathecally synthesized proteins to unravel mechanisms of disease course in multiple sclerosis.
   J Neuroimmunol. 2025;406:578678.
   PubMed         Abstract available
   
   

   
   J Neurol

8. COLEMAN A, Touze A, Farag M, Pengo M, et al
   Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseases.
   J Neurol. 2025;272:501.
   PubMed         Abstract available
   
   
9. HELLMANN MA, Steiner I, Mermelstein M, Friedman I, et al
   Familial myasthenia gravis: characterization of an Israeli cohort and systematic review of the literature.
   J Neurol. 2025;272:498.
   PubMed         Abstract available
   
   
10. NICOLELLA V, Varelli M, Fasano S, Sirica R, et al
    Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis.
    J Neurol. 2025;272:495.
    PubMed         Abstract available
    
    
11. YAGIZ OZOGUL Y, Esatoglu SN, Ozogul M, Kizilkilic O, et al
    Central nervous system involvement and mimickers in ANCA associated vasculitis.
    J Neurol. 2025;272:492.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

12. MASOUD RM, Abdel-Kader NM, Abdel-Ghaffar AB, Moselhy SS, et al
    Association between partial remission phase in type 1 diabetes and vitamin D receptor Fok1 rs2228570 polymorphism.
    J Pediatr Endocrinol Metab. 2024;38:690-697.
    PubMed         Abstract available
    
    

    
    Mult Scler

13. BOFFA G, Genchi A, Mariottini A, Brittain G, et al
    Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.
    Mult Scler. 2025 Jul 7:13524585251349129. doi: 10.1177/13524585251349129.
    PubMed         Abstract available
    
    
14. LEBRUN-FRENAY C, Okuda DT
    High-risk populations should be screened for multiple sclerosis: No.
    Mult Scler. 2025 Jul 8:13524585251353025. doi: 10.1177/13524585251353025.
    PubMed        
    
    
15. BECZEK A, Landt EM, Magyari M, Storr LK, et al
    Assessing the association between mortality and clinical follow-up visits in multiple sclerosis.
    Mult Scler. 2025 Jul 7:13524585251353079. doi: 10.1177/13524585251353079.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

16. EINSIEDLER M, Zecca C, Hofer L, Benkert P, et al
    Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort.
    Neurol Clin Pract. 2025;15:e200499.
    PubMed         Abstract available
    
    

    
    PLoS One

17. WANG K, Xu P, Lu J, Ji X, et al
    Circadian rhythm genes and immune cell infiltration in myasthenia gravis: A comprehensive analysis.
    PLoS One. 2025;20:e0327829.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.